Krónikus aktív B hepatitis interferon (Egiferon) kezelése.

E. Ibrányi, E. Nagy, F. Szalay, G. Horváth, K. Dávid

Research output: Article

3 Citations (Scopus)


Human leukocyta interferon (Egiferon) has been administered in 10 cases having HBsAg positive chronic active hepatitis. The treatment was started with 3 x 3 MU week for one month and either with 2 x 3 MU week or 3 x 3 MU week for 2 subsequent months. HBsAg negativity was found in cases of 4 and histological improvement in cases of 3 patients. The treatment was ineffective in 3 cases.

Translated title of the contributionInterferon (Egiferon) therapy of chronic active hepatitis
Original languageHungarian
Pages (from-to)2645-2647
Number of pages3
JournalOrvosi hetilap
Issue number48
Publication statusPublished - nov. 28 1993

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Krónikus aktív B hepatitis interferon (Egiferon) kezelése.'. Together they form a unique fingerprint.

  • Cite this

    Ibrányi, E., Nagy, E., Szalay, F., Horváth, G., & Dávid, K. (1993). Krónikus aktív B hepatitis interferon (Egiferon) kezelése. Orvosi hetilap, 134(48), 2645-2647.